Myeliyon Pharmaceutical Private Limited
Pharmaceutical company that trades and manufactures medical products such as hand sanitizer and thermometers.
2018 | Mumbai, Maharashtra (India) | Active
Myeliyon Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.50 Cr
- Revenue Growth 1.42%
- Profit Growth -1903.20%
- Ebitda -1521.22%
- Net Worth 431.91%
- Total Assets 193.24%
About Myeliyon Pharmaceutical
Myeliyon Pharmaceutical Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 October 2018 (Six years and four months 3 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.50 Cr.
Ramesh Sanjeeva, Karunakar Bhoja, and Syed Zafer serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299MH2018PTC316442
- Company No.
316442
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Healthcare
Who are the key members and board of directors at Myeliyon Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Sanjeeva  | Director | 27-Oct-2018 | Current |
| Karunakar Bhoja | Director | 27-Oct-2018 | Current |
| Syed Zafer | Additional Director | 30-Aug-2019 | Current |
Financial Performance of Myeliyon Pharmaceutical.
Myeliyon Pharmaceutical Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 1.42% increase. The company also saw a substantial fall in profitability, with a 1903.2% decrease in profit. The company's net worth Soared by an impressive increase of 431.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Myeliyon Pharmaceutical?
In 2020, Myeliyon Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹15.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2020 | Indian Bank | ₹1.50 Cr | Open |
How Many Employees Work at Myeliyon Pharmaceutical?
Unlock and access historical data on people associated with Myeliyon Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Myeliyon Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Myeliyon Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.